Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

EMBO Journal

Volumn 16, Issue 10, 1997, Pages 2610-2620

  Nykjaer, Anders ^a   Conese, Massimo ^d   Christensen, Erik I ^a   Olson, David ^b   Cremona, Ottavio ^c   Gliemann, Jørgen ^a   Blasi, Francesco ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c Department of Medical Sciences   (Italy)

^d HSRaffaele   (Italy)

Author keywords

Internalization; Recycling; uPA:serpin complex; Urokinase receptor

Indexed keywords

BIOTIN; CELL SURFACE RECEPTOR; PHOSPHOLIPASE C; SERINE PROTEINASE INHIBITOR; UROKINASE;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITOR COMPLEX; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIGANDS; MICE; MICROSCOPY, FLUORESCENCE; MONOCYTES; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SERPINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030926412     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.10.2610     Document Type: Article

References (60)

1. Argraves, K.M., Battey, F.D., MacCalman, C.D., McCrae, K.R., Gafvels, M., Kozarsky, K.F., Chappell, D.A., Strauss, J.E., III and Strickland, D.K. (1995) The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type 1 complexes. J. Biol. Chem., 270, 26550-26557.
2. 2-terminal amino acid sequence and glycosylation variants. J. Biol. Chem., 265, 6453-6460.
3. Bergmann, B., Scott, R., Bajpai, A., Watts, A. and Baker, J. (1986) Inhibition of tumor-cell mediated extracellular matrix destruction by a fibroblasts proteinase-inhibitor, protease-nexin 1. Proc. Natl Acad. Sci. USA, 88, 8342-8346.
4. Besser, D., Verde, P., Nagamine, Y. and Blasi, F. (1996) Signal transduction and the uPA/uPAR system. Fibrinolysis. 10, 215-237.
5. Bianchi, E., Ferrero, E., Fazioli, F., Mangili, F. Wang, J., Bender, J.R., Blasi, F. and Pardi, R. (1996) Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J. Clin. Invest., 98, 1133-1141.
6. Blasi, F., Vassalli, J.-D. and Danø, K. (1987) Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J. Cell Biol., 104, 801-804.
7. Blasi, F. et al. (1994) The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis, 8 (Suppl. 1), 182-188.
8. Bohuslav, J., Horejsi, V., Hansmann, C., Stöck J., Weidle, U.H., Majdic, O., Bartke, I., Knapp, W. and Stockinger, H. (1995) Urokinase plasminogen activator receptor, beta-2 integrins and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med., 181, 1381-1390.
9. Busso, N., Masur, S.K., Lazega, D., Waxman, S. and Ossowski, L. (1994) Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol., 126, 259-270.
10. Conese, M., Olson, D. and Blasi, F. (1994) Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and α2-macroglobulin receptor. J. Biol. Chem., 269, 17886-17892.
11. Conese, M., Nykjær, A., Petersen, C.M., Cremona, O., Pardi, R., Andreasen, P.A., Gliemann, J., Christensen, E.I. and Blasi, F. (1995) α2-macroglobulin receptor/LDL receptor-related protein (LRP)-dependent internalization of the urokinase receptor. J. Cell Biol., 131, 1609-1622.
12. Crowley, C.W., Cohen, R.L., Lucas, B.K., Liu, G., Shuman, M.A. and Levinson, A.D. (1993) Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl Acad. Sci. USA, 90, 5021-5025.
13. Cubellis, M.V., Nolli, M.L., Cassani, G. and Blasi, F. (1986) Binding of single-chain pro-urokinase to the urokinase receptors on human U937 cells. J. Biol. Chem., 261, 15819-15822.
14. Cubellis, M.V., Wun, T.-C. and Blasi, F. (1990) Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J., 9, 1079-1085.
15. Danø, K., Behrendt, N., Brunner, N., Ellis, V., Plough, M. and Pyke, C. (1994) The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8 (Suppl. 1), 189-203.
16. Deng, G., Curriden, S.A., Wang, S., Rosenberg, S. and Loskutoff, D.J. (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase-receptor-mediated cell adhesion and release? J. Cell Biol., 134, 1563-1571.
17. Ellis, V., Behrendt, N. and Danø, K. (1991) Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem., 266, 12752-12758.
18. Estreicher, A., Mulhauser, J., Carpentier, J.-L., Orci, L. and Vassalli, J.-D. (1990) The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol., 111, 783-792.
19. Fazioli, F. and Blasi, F. (1994) Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? Trends Pharmacol. Sci., 15, 25-29.
20. Griffiths, G., McDowall, A., Back, R. and Dubochet, J. (1984) On the preparation of cryosections for immunocytochemistry. J. Ultrastruct. Res., 89, 65-78.
21. Grøndahl-Hansen, J., Peters, H.A., van Putten, W.L.J., Rønne, E., Danø, K., Klijn, J.G.M., Brünner, N. and Foekens, J.A. (1995) Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin. Cancer Res., 1, 1079-1087.
22. Gyetko, M.R., Chen, G.-H., McDonald, R.A., Goodùan, R., Huffnagle, G.B., Wilkinson, C.C., Fuller, J.A. and Toews, G.B. (1996) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest., 97, 1818-1826.
23. Hearing, V., Law, L.W., Corti, A., Appella, E. and Blasi, F. (1988) Modulation of the metastatic potential by cell surface urokinase of murine cells. Cancer Res., 48, 1270-1278.
24. Heegaard, C.W., Simonsen, A.C.W., Oka, K., Kjøller, L., Christensen, A., Madsen, B., Ellgaard, L., Chan, L. and Andreasen, P.A. (1995) Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J. Biol. Chem., 270, 20855-20861.
25. Herz, J., Goldstein, J.L., Strickland, D.K., Ho, Y.K. and Brown, M.S. (1991) 39 kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2 macroglobulin receptor. J. Biol. Chem., 266, 21232-21236.
26. Herz, J., Clouthier, D.E. and Hammer, R.E. (1992) LDL receptor related protein internalizes and degrades uPA:PAI-1 complexes and is essential for embryo implantation. Cell, 71, 411-421.
27. Holmberg, L., Bladu, B. and Åstedt, B. (1976) Purification of urokinase by affinity chromatography. Biochim. Biophys. Acta, 445, 215-222.
28. Jensen, P.H., Christensen, E.I., Ebbesen, P., Gliemann, J. and Andreasen, P.A. (1990) Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regul., 1, 1043-1056.
29. Krieger, M. and Herz, J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem., 63, 601-637.
30. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
31. Min, H.Y., Doyle, L.V., Vitt, C.R., Zandonella, C.L., Stratton-Thomas, J.R., Shuman, M.A. and Rosenberg, A. (1996) Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res., 56, 2428-2433.
32. Moestrup, S.K. and Gliemann, J. (1991) Analysis of ligand recognition by purified α2-macroglobulin receptor (low density lipoprotein-related protein). Evidence that high affinity of α2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. J. Biol. Chem., 266, 14011-14020.
33. Moestrup, S.K., Kaltoft, K., Sottrup-Jensen, L. and Gliemann, J. (1990) The human α2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition. J. Biol. Chem., 265, 12623-12628.
34. Moestrup, S.K., Gliemann, J. and Pallesen, G. (1992) Distribution of the alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res., 269, 375-382.
35. Moestrup, S.K., Nielsen, S., Andreasen, P., Jørgensen, K.E., Nykær, A., Røigaard, H., Gliemann, J. and Christensen, E.I. (1993) Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J. Biol. Chem., 268, 16564-16570.
36. Møller, L.B., Ploug, M. and Blasi, F. (1992) Structural requirements for glycosyl-phosphatidyl inositol anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur. J. Biochem., 208, 493-500.
37. Møller, L.B., Pöllänen, J., Rønne, E., Pedersen, N. and Blasi, F. (1993) N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J. Biol. Chem., 268, 11152-11159.
38. Nykjær, A. et al. (1992) Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem., 267, 14543-14546.
39. Nykjær, A., Kjøller, L., Cohen, L.R., Lawrence, D.A., Garni-Wagner, B.A., Todd, R.F., III, van Zonneveld, A.-J., Gliemann, J. and Andreasen, P.A. (1994a) Regions involved in binding of urokinase type-1 inhibitor complex and pro-urokinase to the endocytic α2-macroglobulin receptor/LDL receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J. Biol. Chem., 269, 25668-25676.
40. Nykjær, A., Møller, B., Todd, R.F., III. Christensen, T., Andreasen, P.A., Gliemann, J. and Petersen, C.M. (1994b) Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol. 152, 505-516.
41. Olson, D., Pöllänen, J., Høyer-Hansen, G., Rønne, E., Sakaguchi, K., Wun, T.-C., Appella, E., Danø, K. and Blasi, F. (1992) Internalization of the urokinase-plasminogen activator inhibitor-type 1 complex is mediated by the urokinase receptor. J. Biol. Chem., 267, 9129-9133.
42. Orth, K., Madison, E.L., Gething, M.-J., Sambrook, J.F. and Herz, J. (1992) Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen activator inhibitor type-1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor. Proc. Natl Acad. Sci. USA, 89, 7422-7426.
43. Ossowski, L. (1988) In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface bound urokinase. J. Cell Biol., 107, 2437-2445.
44. Ossowski, L. and Reich, E. (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 52, 321-328.
45. Ossowski, L., Clunie, G., Masucci, M.T. and Blasi, F. (1991) In vivo interaction between urokinase and its receptor: effect on tumor cell invasion. J. Cell Biol., 115, 1107-1112.
46. Picone, R. et al. (1989) Regulation of urokinase receptors in monocyte-like U937 cells by phorbol esters phorbol myristate acetate. J. Cell Biol., 108, 693-702.
47. Ploug, M., Rønne, E., Behrendt, N., Jensen, A.L., Blasi, F. and Danø, K. (1991) Cellular receptor for urokinase plasminogen activator: carboxyl terminal processing and membrane anchoring. J. Biol. Chem., 266, 1926-1933.
48. Quax, P.H.A., Pedersen, N., Masucci, M.T., Weening-Verhoeff, E.J.D., Danø, K., Verheijen, J.H. and Blasi, F. (1991) Complementation analysis of extracellular matrix degradation: enhancement of urokinase plasminogen activation by the urokinase receptor. Cell Regulation, 2, 793-803.
49. Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. and Fazioli, F. (1996) Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J., 15, 1572-1582.
50. Roldan, A.L., Cubellis, M.V., Masucci, M.T., Behrendt, N., Lund, L.R., Danø, K. and Blasi, F. (1990) Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface plasmin dependent proteolysis. EMBO J., 9, 467-474.
51. Rønne, E., Behrendt, N., Ellis, V., Ploug, M., Danø, K. and Høyer-Hansen, G. (1991) Cell induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the N-terminal domain of the urokinase receptor. FEBS Lett., 288, 233-236.
52. Sherman, P.M., Lawrence, D.A., Yang, A.Y., Vanderberg, E.T., Paielli, D., Olson, S.T., Shore, J.D. and Ginsburg, D. (1992) Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J. Biol. Chem., 267, 7588-7595.
53. vβ3 binding to vitronectin. Nature, 383, 441-443.
54. Stephens, R.W., Pöllänen, J., Tapiovaara, H., Leung, K.C., Sim, P.S., Salonen, E.M., Rønne, E., Behrendt, N., Danø, K. and Vaheri, A. (1989) Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol., 108, 1987-1995.
55. Stoppelli, M.P., Corti, A., Soffientini, A., Cassani, G., Blasi, F. and Assoian, R.K. (1985) Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl Acad. Sci. USA, 82, 4939-4943.
56. Stoppelli, M.P., Tacchetti, C., Cubellis, M.V., Corti, A., Hearing, V.J., Cassani, G., Appella, E. and Blasi, F. (1986) Autocrine saturation of pro-urokinase receptor on human A431 cells. Cell, 45, 675-684.
57. Tokuyasu, K.T. (1978) A study of positive staining of ultrathin frozen sections. J. Ultrastruct. Res., 63, 287-307.
58. Vassalli, J.-D., Baccino, D. and Belin, D. (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator urokinase. J. Cell Biol., 100, 86-92.
59. Wei, Y. Waltz, D.A., Rao, N., Drummond, R.J., Rosenberg, S. and Chapman, H.A. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem., 269, 32380-32388.
60. Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C. Rosenberg, S., Doyle, M.V. and Chapman, H.A. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551-1555.